Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
- PMID: 32853686
- PMCID: PMC7445123
- DOI: 10.1016/j.diabres.2020.108382
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
Abstract
Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a poorer outcome compared with normoglycemic individuals and people with pre-existing diabetes.
Keywords: COVID-19; New-onset diabetes; New-onset hyperglycemia; Outcomes; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Yang J.K., Feng Y., Yuan M.Y., Yuan S.Y., Fu H.J., Wu B.Y. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–628. - PubMed
-
- Niu M.J., Yang J.K., Lin S.S., Ji X.J., Guo L.M. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine. 2008;34:56–61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous